Tegavivint suppresses progression and metastasis of osteosarcoma via blockade of Wnt signaling/ALDH1 axis: Preclinical study of a novel Wnt/beta-catenin pathway inhibitor
- Resource Type
- Journal
- Source
CANCER RESEARCH ; JUL 2018, 78 13, 2p. Supplement: S- Subject
- Language
- English
- ISSN
- 15387445